Edesa Biotech, Inc. (EDSA) vs EyePoint, Inc. (EYPT)
- Edesa Biotech, Inc. EDSA 2.17 +1.88%
- EyePoint, Inc. EYPT 0.36 0.00%
Edesa Biotech, Inc. and EyePoint, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and EyePoint, Inc. are of similar size ($30.7M and $28.8M). Edesa Biotech, Inc. grew revenue faster over the last twelve months: −43.5% against −94.6%. Edesa Biotech, Inc. has the higher net margin (0.00% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Edesa Biotech, Inc. leads on 8 and EyePoint, Inc. on 8.
Valuation
Profitability
| Metric | EDSA | EYPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 41.75% | 68.51% |
| Operating margin | 0.00% | (11,369.30%) | 0.00% |
| Net margin | 0.00% | (10,998.67%) | 0.00% |
| Free cash flow margin | 0.00% | (9,724.68%) | 0.00% |
| Return on equity | (531.32%) | (148.70%) | (51.96%) |
| Return on assets | (102.46%) | (115.86%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack